See What HealthDay Can Do For You
Contact Us

Drinking Coffee Cuts Risk of Liver Cirrhosis Mortality

Coffee appears to have a protective effect against mortality related to non-viral hepatitis

Drinking Coffee Cuts Risk of Liver Cirrhosis Mortality

TUESDAY, April 8, 2014 (HealthDay News) -- Coffee consumption is associated with reduced risk of mortality from cirrhosis related to non-viral hepatitis, according to research published online in Hepatology.

George Boon-Bee Goh, M.B.B.S., M.R.C.P., of the Singapore General Hospital, and colleagues analyzed data from a prospective population-based cohort of 63,275 middle-aged and older Chinese individuals. The authors sought to assess the association between consumption of coffee or other beverages and risk of cirrhosis mortality.

The researchers observed a strong dose-dependent inverse association between coffee intake and risk of cirrhosis mortality related to non-viral hepatitis (P for trend = 0.013). Compared with individuals who did not drink coffee daily, those who drank two or more cups of coffee per day were at significantly reduced risk for mortality from cirrhosis related to non-viral hepatitis (hazard ratio, 0.34; 95 percent confidence interval, 0.14 to 0.80). No association was found between coffee consumption and cirrhosis mortality related to hepatitis B. Consumption of other beverages, including black tea, green tea, fruit juices, or soft drinks, was not associated with risk of cirrhosis mortality.

"This study demonstrates the protective effect of coffee on non-viral hepatitis related cirrhosis mortality, and provides further impetus to evaluate coffee as a potential therapeutic agent in patients with cirrhosis," the authors write.

Full Text (subscription or payment may be required)

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.